Identifiers | |
---|---|
IUPAC name
| |
PubChem CID | |
Chemical and physical data | |
Formula | C22H26N4O3 |
Molar mass | 394.475 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Ethyleneoxynitazene (Tetrahydrofuranitazene) is a benzimidazole derivative which has been sold as a designer drug over the internet and presumably has opioid effects. It is an analogue of etonitazene where the 4-ethoxy group attached to the benzyl ring has been cyclised round to the 3-position to form a 2,3-dihydrobenzofuran ring system. It was first reported in Estonia in February 2023, subsequently in the UK in late 2023 and in China July 1st.
See also
- Etonitazepyne
- Etomethazene
- Isotonitazene
- Methylenedioxynitazene
- List of benzimidazole opioids
- Substituted benzofuran
References
- "New psychoactive substances - the current situation in Europe" (PDF). European Drug Report. European Union Drugs Agency (EUDA). 2024.
- "Third addendum to ACMD report on the use and harms of 2-benzyl benzimidazole ('nitazene') and piperidine benzimidazolone ('brorphine-like') opioids" (PDF). Advisory Council on the Misuse of Drugs. 15 December 2023.
- "Reddit - Dive into anything". www.reddit.com. Retrieved 2024-10-16.
This analgesic-related article is a stub. You can help Misplaced Pages by expanding it. |